These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6600426)

  • 1. Gastric adaptation occurs with aspirin administration in man.
    Graham DY; Smith JL; Dobbs SM
    Dig Dis Sci; 1983 Jan; 28(1):1-6. PubMed ID: 6600426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do infiltrating leukocytes contribute to the adaptation of human gastric mucosa to continued aspirin administration?
    Stachura J; Konturek JW; Dembinski A; Domschke W
    Scand J Gastroenterol; 1994 Nov; 29(11):966-72. PubMed ID: 7871375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Konturek JW; Dembiński A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Sep; 48(3):383-91. PubMed ID: 9376621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth, and neutrophil activation.
    Konturek JW; Dembinski A; Stoll R; Domschke W; Konturek SJ
    Gut; 1994 Sep; 35(9):1197-204. PubMed ID: 7959223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric adaptation. Studies in humans during continuous aspirin administration.
    Graham DY; Smith JL; Spjut HJ; Torres E
    Gastroenterology; 1988 Aug; 95(2):327-33. PubMed ID: 3260568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aspirin and an aspirin-acetaminophen combination on the gastric mucosa in normal subjects. A double-blind endoscopic study.
    Graham DY; Smith JL
    Gastroenterology; 1985 Jun; 88(6):1922-5. PubMed ID: 3873372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man.
    Konturek JW; Dembinski A; Stoll R; Konturek M; Domschke W
    Scand J Gastroenterol; 1993 Sep; 28(9):767-71. PubMed ID: 8235431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
    Stiel D; Ellard KT; Hills LJ; Brooks PM
    Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
    Hawkey CJ; Hawthorne AB; Hudson N; Cole AT; Mahida YR; Daneshmend TK
    Clin Sci (Lond); 1991 Oct; 81(4):565-73. PubMed ID: 1657506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans.
    Metzger WH; McAdam L; Bluestone R; Guth PH
    Am J Dig Dis; 1976 Nov; 21(11):963-8. PubMed ID: 790946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS
    N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
    Lanza FL; Rack MF; Wagner GS; Balm TK
    Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
    Konturek JW; Dembinski A; Konturek SJ; Stachura J; Domschke W
    Gastroenterology; 1998 Feb; 114(2):245-55. PubMed ID: 9453483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and the stomach.
    Graham DY; Smith JL
    Ann Intern Med; 1986 Mar; 104(3):390-8. PubMed ID: 3511824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
    Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
    Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
    Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
    Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aspirin prolong bleeding from gastric biopsies in man?
    O'Laughlin JC; Hoftiezer JW; Mahoney JP; Ivey KJ
    Gastrointest Endosc; 1981 Feb; 27(1):1-5. PubMed ID: 6971236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ranitidine protects the human stomach and duodenal mucosa against low-dose acetylsalicylic acid].
    Müller P; Damman HG; Marinis E; Simon B
    Z Gastroenterol; 1989 Dec; 27(12):722-4. PubMed ID: 2697116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of H2-receptor blockers in the prevention of gastric injury resulting from nonsteroidal anti-inflammatory agents.
    Kimmey MB; Silverstein FE
    Am J Med; 1988 Feb; 84(2A):49-52. PubMed ID: 3258124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
    Hoftiezer JW; O'Laughlin JC; Ivey KJ
    Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.